Latest Breaking News On - Human leukocyte antigens - Page 1 : vimarsana.com

Hansa Biopharma AB: Hansa Biopharma Completes Randomization in Pivotal Phase 3 US ConfIdeS Trial

Hansa Biopharma AB: Hansa Biopharma Completes Randomization in Pivotal Phase 3 US ConfIdeS Trial
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-kingdom
Jordan
Stockholm
Sweden
Prnewswire-hansa-biopharma
Hansa-biopharma
Stephanie-kenney
Evan-ballantyne
Linkedin
European-medicines-agency
International-phase
Vp-global-corporate-affairs

Hansa Biopharma Completes Randomization in Pivotal Phase 3 US ConfIdeS Trial

Hansa Biopharma Completes Randomization in Pivotal Phase 3 US ConfIdeS Trial
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Stockholm
Sweden
Jordan
Hansa-biopharma
Stephanie-kenney
Evan-ballantyne
Prnewswire-hansa-biopharma
European-union
European-medicines-agency
Vp-global-corporate-affairs
Linkedin

Hansa Biopharma AB: Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting

LUND, Sweden, May 21, 2024 /PRNewswire/ --. Hansa Biopharma, "Hansa" (NASDAQ: HNSA) (STOCKHOLM: HNSA), today announced data featuring imlifidase will be presented at the American Transplant

United-kingdom
United-states
Sweden
Jordan
France
Stockholm
American
French
Evan-ballantyne
Hansa-biopharma
Stephanie-kenney
European-medicines-agency

Hull mum who was UK's first female double hand transplant patient now receives 'world first' treatment to prevent rejection

Hull mum who was UK's first female double hand transplant patient now receives 'world first' treatment to prevent rejection
hulldailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hulldailymail.co.uk Daily Mail and Mail on Sunday newspapers.

United-kingdom
Simon-kay
Corinne-hutton
Charlotte-blacklock-lumb
Andrea-leadsome
James-griffin
Therapeutic-plasma-exchange
Therapeutic-apheresis-services
Leeds-general-infirmary
Antibody-mediated-rejection
Human-leukocyte-antigens
Professor-simon-kay

Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment

Tevogen Bio Holdings Inc. Tevogen’s ExacTcell platform was d...

Neal-flomenberg
Shannon-rudolph
Tevogen-exactcell
Tevogen-bio
Tevogen-bio-holdings-inc
Semper-paratus-acquisition-corporation-the-business-combination
Tevogen-bio-holdings
Tevogen-bio-
Long-covid
Human-leukocyte-antigens
Chief-scientific
Clinical-scientist

"India has the capability to develop its own innovative gene therapy solutions for thalassemia and sickle cell disease"

"India has the capability to develop its own innovative gene therapy solutions for thalassemia and sickle cell disease"
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

India
Gunjan-sharma
Chimeric-antigen-receptort-cell-therapy
Sickle-cell
Bone-marrow-transplantation
Human-leukocyte-antigens
Gene-therapy

Imlifidase demonstrated 90% patient survival and 82% graft survival at five years in extended pooled analysis with data from 17-HMedIdeS-14 study

/PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced results...

Sweden
United-states
Stockholm
Uppsala
Uppsala-lan
American
Los-angeles
Stanley-jordan
Hansa-biopharma
Stephanie-kenney
Tomas-lorant
Prnewswire-hansa-biopharma

Imlifidase demonstrated 90% patient survival and 82% graft survival at five years in extended pooled analysis with data

LUND, Sweden, Oct. 17, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in...

Sweden
Uppsala
Uppsala-lan
Stockholm
United-states
American
Hansa-biopharmahansa-biopharma
Tomas-lorant
Los-angeles
Hansa-biopharma
Prnewswire-hansa-biopharma
Stanley-jordan

"Increase Awareness on Blood Stem Cell and Bone Marrow Donation to Save Lives in Coimbatore: The Hindu Bureau"

"Increase Awareness on Blood Stem Cell and Bone Marrow Donation to Save Lives in Coimbatore: The Hindu Bureau"
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

Paediatric-hematology
Stem-cell-transplant
Human-leukocyte-antigens
Bone-marrow-transplant-unit

TGA grants provisional approval to Hansa's Idefirix

The Australian Therapeutic Goods Administration (TGA) has granted provisional approval to Hansa Biopharma’s Idefirix (imlifidase).

Sydney
New-south-wales
Australia
Kate-wyburn
Hansa-biopharma
University-of-sydney
Human-leukocyte-antigens